6/21/2023 | CV | Market Commentary: Cerence, World Kinect convertibles on tap; Lumentum lower; Exact Sciences volatile
|
6/21/2023 | CV | Market Commentary: Morning Commentary: World Kinect convertible notes offering on tap; Lantheus active
|
12/8/2022 | CV | Lantheus greenshoe lifts 2.625% convertibles to $575 million
|
12/6/2022 | CV | Market Commentary: Uniti on tap; Axon, Herbalife convertibles eyed; Lantheus, Marriott expand on debut
|
12/6/2022 | CV | Market Commentary: Morning Commentary: Axon, Herbalife convertibles eyed; Lantheus, Marriott surge
|
12/6/2022 | CV | New Issue: Lantheus prices $500 million five-year convertible notes to yield 2.625%, up 42.5%
|
12/5/2022 | CV | Market Commentary: Herbalife, Axon convertibles on deck; Lantheus, Marriott Vacations play to heavy demand
|
12/5/2022 | BK | Lantheus refinances with new $450 million five-year credit facility
|
12/5/2022 | CV | Market Commentary: Morning Commentary: Lantheus, Marriott Vacations convertibles on deck; demand heavy
|
12/5/2022 | CV | Lantheus talks $500 million five-year convertible notes to yield 2.625%-3.125%, up 37.5%-42.5%
|
3/7/2022 | BK | S&P alters Lantheus view to stable
|
3/3/2021 | BKHY | S&P changes Lantheus view to negative
|
8/2/2019 | BKHY | S&P affirms Lantheus
|
7/1/2019 | BK | Lantheus refinances with new $400 million five-year credit facility
|
11/10/2017 | BKHY | S&P lifts Lantheus, facility
|
3/21/2017 | BKHY | S&P rates Lantheus facility B, view positive
|
9/13/2016 | PP | Lantheus prices $40.35 million public stock sale at $7.76 per share
|
9/8/2016 | PP | Lantheus Holdings to conduct public sale of 5.2 million common shares
|
9/8/2016 | BK | Lantheus to repay $55 million under credit facilities via stock, cash
|
6/30/2015 | PP | Lantheus greenshoe exercised for $73.54 million IPO of common stock
|
6/25/2015 | PP | Lantheus prices $65 million initial public offering of stock at $6.00
|
6/24/2014 | HYLM | Lantheus to redeem portion of 9¾% notes with proceeds from stock sale
|